(Q49179704)

19 February 2018

title

Effect of heart failure on dipeptidyl peptidase IV activity in plasma of dogs. (English)

1 reference

19 February 2018

0 references

N Gomez

1

1 reference

19 February 2018

V Matheeussen

2

1 reference

19 February 2018

C Damoiseaux

3

1 reference

19 February 2018

A Tamborini

4

1 reference

19 February 2018

A C Merveille

5

1 reference

19 February 2018

P Jespers

6

1 reference

19 February 2018

C Michaux

7

1 reference

19 February 2018

C Clercx

8

1 reference

19 February 2018

I De Meester

9

1 reference

19 February 2018

K Mc Entee

10

1 reference

19 February 2018

publication date

18 May 2012

1 reference

19 February 2018

Journal of Veterinary Internal Medicine

published in

1 reference

19 February 2018

volume

26

1 reference

19 February 2018

issue

4

1 reference

19 February 2018

page(s)

929-934

1 reference

19 February 2018

Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00942.X

Up-regulation of 'clearance' receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00942.X

Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00942.X

Molecular forms of human brain natriuretic peptide in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00942.X

Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00942.X

Proposed guidelines for the diagnosis of canine idiopathic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00942.X

Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00942.X

Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00942.X

Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00942.X

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00942.X

Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00942.X

Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00942.X

Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2012.00942.X

10.1111/J.1939-1676.2012.00942.X

21 January 2018

Identifiers

DOI

1 reference

19 February 2018

PubMed ID

22594653

1 reference

19 February 2018